Longeveron Inc. Files S-1/A Amendment

TL;DR

Longeveron Inc. filed an S-1/A amendment on 4/5/24. Looks like they're still working on their registration.

AI Summary

Longeveron Inc. filed an S-1/A amendment on April 5, 2024, for its registration statement. The company, located in Miami, Florida, is in the pharmaceutical preparations industry and is incorporated in Delaware. This filing is an amendment to a previous registration, indicating ongoing efforts to comply with SEC regulations for public offerings or reporting.

Why It Matters

This S-1/A filing signifies that Longeveron Inc. is actively engaged in the process of registering securities, which could lead to new investment opportunities or changes in its public trading status.

Risk Assessment

Risk Level: medium — S-1/A filings are typically associated with companies undergoing registration processes, which can involve significant financial and regulatory complexities.

Key Numbers

• 333-278073 — SEC File Number (Identifies the specific SEC registration)
• 24827417 — Film Number (Internal SEC processing number)

Key Players & Entities

• Longeveron Inc. (company) — Registrant
• April 5, 2024 (date) — Filing Date
• Miami, Florida (location) — Company Address
• Delaware (location) — State of Incorporation
• Wa'el Hashad (person) — Chief Executive Officer

FAQ

Key Financial Figures

• $0.001 — of our Class A common stock, par value $0.001 per share ("Class A common stock"), and
• $3 — accompanying Class A common warrant is $3.25, which is equal to the closing price
• $0 — d to the public in this offering, minus $0.001, and the exercise price of each pre
• $2.75 — aq Capital Market on April 2, 2024, was $2.75 per share. All share, Class A common wa
• $3.25 — sumed combined public offering price of $3.25 per share and the accompanying Class A
• $3.249 — accompanying Class A common warrant and $3.249 per pre -funded warrant and the accompa
• $35,000 — accountable expenses in an amount up to $35,000, and legal fees and other out -of-pocke
• $100,000 — -pocket expenses in the amount of up to $100,000. In addition, we have agreed to issue t

Filing Documents

• ea0202023-03.htm (S-1/A) — 1016KB
• ea020202303ex23-1_longeveron.htm (EX-23.1) — 2KB
• timage_001.jpg (GRAPHIC) — 8KB
• timage_002.jpg (GRAPHIC) — 8KB
• timage_003.jpg (GRAPHIC) — 5KB
• tlongeveron_logo.jpg (GRAPHIC) — 94KB
• ex23-1_001.jpg (GRAPHIC) — 6KB
• ex23-1_002.jpg (GRAPHIC) — 3KB
• 0001213900-24-030874.txt ( ) — 1509KB
• lgvn-20231231.xsd (EX-101.SCH) — 3KB
• lgvn-20231231_def.xml (EX-101.DEF) — 6KB
• lgvn-20231231_lab.xml (EX-101.LAB) — 9KB
• lgvn-20231231_pre.xml (EX-101.PRE) — 6KB
• ea0202023-03_htm.xml (XML) — 4KB

USE OF PROCEEDS

USE OF PROCEEDS 25

SELECTED FINANCIAL DATA

SELECTED FINANCIAL DATA 26 DIVIDEND POLICY 27

DESCRIPTION OF SECURITIES WE ARE OFFERING

DESCRIPTION OF SECURITIES WE ARE OFFERING 30 PLAN OF DISTRIBUTION 35 LEGAL MATTERS 38 WHERE YOU CAN FIND MORE INFORMATION 39

SIGNATURES

SIGNATURES II-8 Neither we nor the placement agent have authorized anyone to provide you with information other than that contained in this prospectus, or any free writing prospectus prepared by or on our behalf or to which we have referred you. We and the placement agent take no responsibility for and can provide no assurance as to the reliability of, any other information that others may give you. We and the placement agent are offering to sell, and seeking offers to buy, securities only in jurisdictions where offers and sales are permitted. The information contained in this prospectus is accurate only as of the date on the front cover page of this prospectus, or other earlier date stated in this prospectus, regardless of the time of delivery of this prospectus or of any sale of our securities. Our business, financial condition, results of operations and future prospects may have changed since that date. No action is being taken in any jurisdiction outside the United States to permit a public offering of our securities or possession or distribution of this prospectus in that jurisdiction. Persons who come into possession of this prospectus in jurisdictions outside the United States are required to inform themselves about and to observe any restrictions as to this offering and the distribution of this prospectus applicable to that jurisdiction. We and the placement agent are offering to sell, and seeking offers to buy, our securities only in jurisdictions where offers and sales are permitted. Neither we nor the placement agent have done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside of the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of our shares of Class A common stock, Class A common warrants and pre -funde

View Full Filing

View this S-1/A filing on SEC EDGAR